Cytologic assessment of thyroid nodules - Updates in 2023 Bethesda reporting system, diagnostic challenges and pitfalls
This review summarizes changes and updates in the most recently published 2023 Bethesda System for Thyroid Cytopathology (TBSRTC). Further, the review focuses on challenges and pitfalls encountered in cytologic assessment of thyroid fine needle aspiration (FNA) specimens, with an emphasis on atypia...
Saved in:
Main Authors: | Xiaobing Jin (Author), Xin Jing (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Use of the Bethesda system for the cytologic diagnosis of thyroid nodules
by: Rafael Escalona Veloz
Published: (2023) -
Bethesda Category III thyroid nodules: descriptive cytological aspects of a series
by: Júlia Thalita Queiroz Rocha, et al.
Published: (2023) -
Management of Thyroid Nodules and Thyroid Cancer: A Curriculum Based on American Thyroid Association Guidelines with Bethesda System of Reporting Thyroid Cytopathology Correlation
by: Puneet Bhargava, et al.
Published: (2013) -
The Bethesda system for reporting thyroid cytopathology: into the clinic
by: Wu HH, et al.
Published: (2015) -
What's new in thyroid pathology 2024: updates from the new WHO classification and Bethesda system
by: Andrey Bychkov, et al.
Published: (2024)